4//SEC Filing
Cearnal Martin E 4
Accession 0001209191-22-026154
CIK 0001087294other
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 1:11 PM ET
Size
7.0 KB
Accession
0001209191-22-026154
Insider Transaction Report
Form 4
Cearnal Martin E
Director
Transactions
- Other
Common Stock
2022-03-17$2.74/sh−15,000$41,100→ 163,473 total - Other
Options (right to buy)
2022-03-17−5,000→ 0 totalExercise: $3.22From: 2025-03-17Exp: 2031-03-17→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]Mr. Cearnal passed away on March 17, 2022. All unvested equity awards forfeited upon death.
Documents
Issuer
CUMBERLAND PHARMACEUTICALS INC
CIK 0001087294
Entity typeother
Related Parties
1- filerCIK 0001408500
Filing Metadata
- Form type
- 4
- Filed
- Apr 28, 8:00 PM ET
- Accepted
- Apr 29, 1:11 PM ET
- Size
- 7.0 KB